Febuxostat 80 mg/1 (Febuxostat TABLET, FILM COATED) 80 mg/1

Febuxostat 80 mg tablets are used to manage certain types of gout. This medication helps reduce uric acid levels in the body. Learn more about Febuxostat uses and effects.

Strength

80 mg/1

Pack Size

30 TABLET, FILM COATED in 1 BOTTLE (16714-060-01)

Manufacturer / TM Owner

NorthStar RxLLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Febuxostat is primarily used to lower uric acid levels in individuals with gout. It is often prescribed for those who do not respond well to other treatments. Febuxostat tablets are designed to help prevent gout attacks by reducing the production of uric acid. This medication is not typically used for immediate pain relief but rather for long-term management.

Side Effects

Common effects of Febuxostat may include nausea, diarrhea, and rash. Some individuals might experience dizziness or headache. It is important to note that not everyone will experience these effects, and they may vary in severity. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Febuxostat should be handled with care, especially for those with liver or kidney issues. It is important to follow the prescribed dosage and not to exceed it. Regular monitoring of uric acid levels may be recommended. Always store Febuxostat in a cool, dry place away from direct sunlight.

Avoid Interactions

Febuxostat may interact with certain medications, including those metabolized by the liver. It is advisable to inform your healthcare provider about all medications you are taking. Alcohol consumption should be moderated while using Febuxostat, as it may affect the medication's efficacy. Always consult a healthcare provider for specific interaction concerns.

Frequently Asked Questions

Febuxostat is used to lower uric acid levels in the body, primarily for managing gout.

Febuxostat tablets should be stored in a cool, dry place away from direct sunlight.

Common effects may include nausea, diarrhea, rash, dizziness, and headache.

Yes, Febuxostat may interact with certain medications, especially those metabolized by the liver.

Febuxostat may not be suitable for individuals with certain liver or kidney conditions. Always consult a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.